Singapore markets close in 7 hours 22 minutes

Cardiff Oncology Inc (XE7C.BE)

Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
2.7250+0.1100 (+4.21%)
At close: 08:30PM CEST
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-40,229
-41,441
-38,704
-28,291
-19,307
-
Depreciation & amortisation
410
398
236
451
466
-
Stock-based compensation
4,569
4,509
4,256
3,234
1,765
-
Change in working capital
6,196
6,568
-380
-1,789
-654
-
Other working capital
-30,622
-31,469
-34,826
-23,245
-16,526
-
Other non-cash items
-
-
139
2,032
1,100
703.327
Net cash provided by operating activities
-29,968
-30,887
-33,820
-23,040
-16,315
-
Cash flows from investing activities
Investments in property, plant and equipment
-654
-582
-1,006
-205
-211
-
Purchases of investments
0
-70,084
-91,233
-174,385
0
-
Sales/maturities of investments
0
106,861
130,274
43,142
0
-
Other investing activities
-
-
114
-
-
-
Net cash used for investing activities
33,502
36,195
38,149
-131,448
-211
-
Cash flows from financing activities
Debt repayment
-
-
-
0
-305
0
Common stock issued
-
-
0
34,187
112,300
8,818
Other financing activities
-
-
-
-
-8
-40
Net cash used provided by (used for) financing activities
107
0
75
35,450
137,312
-
Net change in cash
3,641
5,308
4,404
-119,038
120,786
-
Cash at beginning of period
15,017
16,347
11,943
130,981
10,195
-
Cash at end of period
18,658
21,655
16,347
11,943
130,981
-
Free cash flow
Operating cash flow
-29,968
-30,887
-33,820
-23,040
-16,315
-
Capital expenditure
-654
-582
-1,006
-205
-211
-
Free cash flow
-30,622
-31,469
-34,826
-23,245
-16,526
-